Search

  • 联系我们
  • 货号直购

Dynabeads Technology for OEM and Commercial Supply

On this page:

End-to-end support for OEM commercialization and supply

Dynabeads magnetic beads support applications across diagnostics, therapeutics, preventive healthcare, and medical devices. Through Dynabeads Technology—OEM, we help you develop and commercialize products with our proprietary magnetic bead technology.
 

For more than 35 years, we've partnered with biotech, pharmaceutical, diagnostic, and healthcare companies to develop verified magnetic bead solutions. Our OEM supply agreements help ensure consistent product performance and a reliable supply.
 

Our experienced professionals support every stage of development, from bead selection and workflow optimization to scale-up and commercial manufacturing. With access to the full Dynabeads portfolio and widely used manufacturing capabilities, you have the resources to move from development to commercialization with confidence.

Applications

Molecular diagnostic assay development

Create high-performance assays for nucleic acid detection and capture.

Immunodiagnostic assay development

Fast and efficient ligand immobilization for direct and indirect capture of protein biomarkers for use with assay methodologies.

Vaccine development and production

Flexible, dynamic in vitro transcription for highly purified, scalable mRNA synthesis.

Mass spectroscopy

Specific selection and purification of biomolecules for mass spectrometry.

Next generation sequencing (NGS)

Native and conjugated beads to select nucleic acid fragments for library construction.

T cell activation

Optimized pre-conjugated beads for efficient T cell activation and stimulation.

Exosome isolation

Bespoke products and protocols to isolate intact exosomes from body fluid and/or culture media.

Cell separation

Isolate high yields of pure, viable, and functional cells.

Commercial supply with world-class manufacturing

Streamlined inventory management

Our two Norwegian manufacturing facilities operate to International Regulatory quality management standards, helping provide the reassurance of risk-managed, secure supply. For streamlined inventory management, each OEM customer is assigned a Dynabeads project manager who works alongside your operations team to help ensure adequate inventory is available when you need it.

Scale-up of supply

As specialists in production scale-up, our flexible manufacturing capabilities enable seamless expansion of supply—from small prototype batches to bulk production—aligning with your business needs and allowing you to respond rapidly to market demand.

Comprehensive Dynabeads portfolio

In addition to our extensive range of routinely available and standard Dynabeads, we also offer customized bead development, helping ensure you have the most appropriate beads for your needs, and helping to accelerate your time to market.

Our specialist scientists work alongside your R&D team to give advice on which bead product to use and how to optimize the conjugation of ligands and other parameters for optimal performance in your diagnostic assays.

Discuss your requirements with the technical team.

Magnetic beads for leukocyte depletion for circulating tumor cells (CTC) detection

Enable high-quality liquid biopsy sample prep every time with Dynabeads MyOne CD45:

  • Fast binding kinetics for efficient leukocyte depletion, including granulocytes
  • Cost efficiency: 150 µg beads per 106 cells
  • Automation: small bead size (1 µm) for easy and fast automation with KingFisher Sample Purification Systems and microfluidic devices

Success stories

Volition success story

“Volition was able to scale up quickly and reach its target of developing and analytically validating four new Nu.Q assays per quarter, all while adhering to the guidelines of the Clinical and Laboratory Standards Institute (CLSI). Transitioning from our plate-based RUO format to Thermo Fisher beads coupled with the open-access IDS-i10 platform has been transformational in terms of the speed with which we can develop and validate new assays in our discovery pipeline. The combination provides a seamless link from Nu.Q biomarker discovery to clinical test validation through regulatory approval and market launch for our products.”

—Dr. Mark Eccleston, Scientific founder & CTO Volition

For Research Use Only. Not for use in diagnostic procedures.